Comments on 'Current issues in non-inferiority trials'

Statistics in Medicine

Volumn 27, Issue 3, 2008, Pages 333-342

  Koch, Gary G ^a  

^a The University of North Carolina at Chapel Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AMIFOSTINE; ANTIINFECTIVE AGENT; CELECOXIB; CIMETIDINE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; LEFLUNOMIDE; METHOTREXATE; PARACETAMOL; PLACEBO; RANITIDINE;

ACUTE OTITIS MEDIA; CLINICAL RESEARCH; CLINICAL TRIAL; CONFIDENCE INTERVAL; DISEASE FREE SURVIVAL; DOSAGE SCHEDULE COMPARISON; DRUG APPROVAL; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DUODENUM ULCER; HEAD AND NECK CARCINOMA; HUMAN; METHODOLOGY; NONPARAMETRIC TEST; NOTE; OSTEOARTHRITIS; OVERALL SURVIVAL; RECURRENCE RISK; RHEUMATOID ARTHRITIS; RISK BENEFIT ANALYSIS; SAMPLE SIZE; XEROSTOMIA;

CLINICAL TRIALS AS TOPIC; DRUG THERAPY; ENDPOINT DETERMINATION; HUMANS; ODDS RATIO; PLACEBOS; RESEARCH DESIGN; TREATMENT OUTCOME; UNITED STATES;

EID: 38949152645     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.2923     Document Type: Note

References (18)

1. Fleming T. Current issues in non-inferiority trials. Statistics in Medicine 2007, in press.
2. Gough KR, Bardhan KD, Crowe JP et al. Ranitidine and cimetidine in prevention of duodenal ulcer relapse: a double-blind, randomized, multicenter, comparative trial. The Lancet 1984; 324(8404):659-662.
3. Schmid JE, Koch GG, LaVange LM. An overview of statistical issues and methods of meta-analysis. Journal of Biopharmaceutical Statistics 1991; 1(1): 103-120.
4. Silvis SE. Final report on the United States multicenter trial comparing ranitidine to cimetidine as maintenance therapy following healing of duodenal ulcer. Journal of Clinical Gastroenterology 1985; 7:482-487.
5. Pincus T, Chung C, Segurado OG, Amara I, Koch GG. An index of patient reported outcomes (PRO-Index) discriminates effectively between active and control treatment in 4 clinical trials of adalimumab in rheumatoid arthritis. The Journal of Rheumatology 2006; 33(1l):2146-2152.
6. LaVange LM, Durham TA, Koch GG. Randomization-based nonparametric methods for the analysis of multicentre trials. Statistical Methods in Medical Research 2005; 14:281-301.
7. Koch GG, Tangen CM, Jung J-W, Amara IA. Issues for covariance analysis of dichotomous and ordered categorical data from randomized clinical trials and non-parametric strategies for addressing them. Statistics in Medicine 1998; 17:1863-1892.
8. Tangen CM, Koch GG. Complementary nonparametric analysis of covariance for logistic regression in a randomized clinical trial setting. Journal of Biopharmaceutical Statistics 1999; 9(1):45-66.
9. Koch GG. Commentary on 'Statistical consideration of the strategy for demonstrating clinical evidence of effectiveness - one larger vs two smaller pivotal studies'. Statistics in Medicine 2005; 24:1639-1646.
10. Pincus T, Koch G, Lei H, Mangal B, Sokka T, Moskowitz R, Wolfe F, Gibofsky A, Simon L, Zlotnick S, Fort JG. Patient preference for placebo, acetaminophen (paracetamol) or celecoxib efficacy studies (PACES): two randomised, placebo controlled, crossover clinical trials in patients with osteoarthritis of the knee or hip. Annals of the Rheumatic Diseases 2004; 63:931-939.
11. Koch A, Rohmel J. Hypothesis testing in the gold standard design for proving the efficacy of an experimental treatment relative to placebo and a reference. Journal of Biopharmaceutical Statistics 2004; 14(2):315-326.
12. Koch GG, Tangen CM. Nonparametric analysis of covariance and its role in noninferiority clinical trials. Drug Information Journal 1999; 33(4):1145-1159.
13. Pigeot I, Schäfer J, Röhmel J, Hauschke D. Assessing non-inferiority of a new treatment in a three-arm clinical trial including placebo. Statistics in Medicine 2003; 22:883-899.
14. Schwartz TA, Denne JS. A two-stage sample size recalculation procedure for placebo- and active-controlled non-inferiority trials. Statistics in Medicine 2006; 25:3396-3406.
15. Pincus T, Amara I, Koch GG. Continuous indices of core data set measures in rheumatoid arthritis clinical trials. Arthritis and Rheumatism 2005; 52(4):1031-1036.
16. Strand V, Cohen S, Schiff M, Weaver A, Fleischmann R, Cannon G et al. Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Archives Internal Medicine 1999; 159:2542-2550.
17. Committee for Proprietary Medicinal Products (CPMP). Points to Consider on Validity and Interpretation of Meta-Analyses, and One Pivotal Study. CPMP, 2000.
18. Brizel DM, Wasserman TH, Henke M, Vratislav S, Rudat V, Monnier A, Eschwege F, Zhang J, Russell L, Oster W, Sauer R. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. Journal of Clinical Oncology 2000; 18(19):3339-3345.